Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.52B |
| 2 |
Apple
AAPL
|
+$645M |
| 3 |
Amazon
AMZN
|
+$557M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$392M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$354M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$262M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| 1 | Technology | 23.15% |
| 2 | Financials | 13.74% |
| 3 | Communication Services | 10.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Globus Medical
GMED
$7.93B
| $3.72M | ﹤0.01% |
48,046
+34,464
| +254% | +$2.67M |
|
1352
CubeSmart
CUBE
$9.39B
| $3.71M | ﹤0.01% |
80,125
-10,331
| -11% | -$478K |
|
1353
Fate Therapeutics
FATE
$113M
| $3.69M | ﹤0.01% |
42,544
-67,235
| -61% | -$5.84M |
|
1354
SPDR S&P Dividend ETF
SDY
$20.5B
| $3.69M | ﹤0.01% |
30,190
-189
| -0.6% | -$23.1K |
|
1355
FTI Consulting
FCN
$5.32B
| $3.69M | ﹤0.01% |
27,016
+23,585
| +687% | +$3.22M |
|
1356
Choice Hotels
CHH
$5.24B
| $3.68M | ﹤0.01% |
30,988
+1,811
| +6% | +$215K |
|
|
BBBY
1357
DELISTED
Bed Bath & Beyond Inc
BBBY
| $3.67M | ﹤0.01% |
110,161
-163,146
| -60% | -$5.43M |
|
1358
Steven Madden
SHOO
$2.26B
| $3.66M | ﹤0.01% |
83,656
-21,398
| -20% | -$936K |
|
1359
BWX Technologies
BWXT
$15.4B
| $3.66M | ﹤0.01% |
62,981
+15,149
| +32% | +$880K |
|
1360
New Jersey Resources
NJR
$4.73B
| $3.66M | ﹤0.01% |
92,513
+6,791
| +8% | +$269K |
|
|
CS
1361
DELISTED
Credit Suisse Group
CS
| $3.65M | ﹤0.01% |
348,282
-148,112
| -30% | -$1.55M |
|
1362
Iridium Communications
IRDM
$1.91B
| $3.65M | ﹤0.01% |
91,183
-10,135
| -10% | -$405K |
|
|
CIM
1363
Chimera Investment
CIM
$1.15B
| $3.64M | ﹤0.01% |
80,524
-28,099
| -26% | -$1.27M |
|
1364
Matsons
MATX
$3.33B
| $3.64M | ﹤0.01% |
56,868
-32,895
| -37% | -$2.1M |
|
1365
Ryanair
RYAAY
$31B
| $3.64M | ﹤0.01% |
84,035
+76,320
| +989% | +$3.3M |
|
1366
Federal Signal
FSS
$7.66B
| $3.63M | ﹤0.01% |
90,256
-29,141
| -24% | -$1.17M |
|
1367
Renasant Corp
RNST
$3.71B
| $3.63M | ﹤0.01% |
90,680
-11,193
| -11% | -$448K |
|
1368
TD Synnex
SNX
$12.5B
| $3.63M | ﹤0.01% |
29,797
+8,173
| +38% | +$995K |
|
1369
Axsome Therapeutics
AXSM
$5.9B
| $3.62M | ﹤0.01% |
53,717
+18,681
| +53% | +$1.26M |
|
1370
Editas Medicine
EDIT
$245M
| $3.6M | ﹤0.01% |
63,594
-40,923
| -39% | -$2.32M |
|
1371
PotlatchDeltic
PCH
$3.25B
| $3.6M | ﹤0.01% |
67,811
-301
| -0.4% | -$16K |
|
1372
Nektar Therapeutics
NKTR
$899M
| $3.59M | ﹤0.01% |
13,958
+12,790
| +1,095% | +$3.29M |
|
1373
Kinsale Capital Group
KNSL
$10.1B
| $3.59M | ﹤0.01% |
21,785
-1,424
| -6% | -$235K |
|
|
GWB
1374
DELISTED
Great Western Bancorp, Inc.
GWB
| $3.58M | ﹤0.01% |
109,252
+8,548
| +8% | +$280K |
|
1375
Brighthouse Financial
BHF
$2.83B
| $3.57M | ﹤0.01% |
78,476
+27,564
| +54% | +$1.26M |
|